Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) Income from Continuing Operations: 2012-2025

Historic Income from Continuing Operations for Ptc Therapeutics (PTCT) over the last 14 years, with Sep 2025 value amounting to $15.9 million.

  • Ptc Therapeutics' Income from Continuing Operations rose 114.90% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $489.4 million, marking a year-over-year increase of 190.32%. This contributed to the annual value of -$625.6 million for FY2024, which is 12.53% up from last year.
  • Per Ptc Therapeutics' latest filing, its Income from Continuing Operations stood at $15.9 million for Q3 2025, which was up 124.51% from -$64.8 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Income from Continuing Operations ranged from a high of $866.6 million in Q1 2025 and a low of -$328.2 million during Q4 2024.
  • In the last 3 years, Ptc Therapeutics' Income from Continuing Operations had a median value of -$106.7 million in 2024 and averaged -$47.6 million.
  • As far as peak fluctuations go, Ptc Therapeutics' Income from Continuing Operations plummeted by 91.74% in 2021, and later surged by 1,046.28% in 2025.
  • Over the past 5 years, Ptc Therapeutics' Income from Continuing Operations (Quarterly) stood at -$143.3 million in 2021, then fell by 21.82% to -$174.5 million in 2022, then crashed by 40.05% to -$244.4 million in 2023, then crashed by 34.27% to -$328.2 million in 2024, then surged by 114.90% to $15.9 million in 2025.
  • Its Income from Continuing Operations was $15.9 million in Q3 2025, compared to -$64.8 million in Q2 2025 and $866.6 million in Q1 2025.